Keane Celia, Young Mike
Department of General Surgery, MidCentral District Health Board, Palmerston North, New Zealand.
ANZ J Surg. 2014 Oct;84(10):758-62. doi: 10.1111/ans.12409. Epub 2013 Oct 8.
New Zealand has one of the highest rates of rectal adenocarcinoma in the world. Magnetic resonance imaging (MRI) is widely used for preoperative staging of rectal cancer. The accuracy of MRI varies, which may affect treatment decisions. The accuracy of MRI for pretreatment staging of rectal adenocarcinoma in a provincial centre in New Zealand has not been investigated. We aimed to assess the accuracy of MRI for pretreatment staging of early rectal adenocarcinoma in patients managed via the MidCentral Regional Cancer Service Multidisciplinary Team.
A retrospective review of the MidCentral Regional Cancer Service Multidisciplinary Team database identified 54 patients with rectal adenocarcinoma who proceeded to surgery without preoperative long course chemo-radiotherapy. The pretreatment MRI stage was compared with the histological stage for each of these patients.
MRI correctly staged the tumour invasion (T stage) in 24 patients (44% of cases), and lymph node stage in 38 patients (70% of cases). There was moderate agreement between MRI and histological staging for tumour invasion (κ=0.46) and for lymph node involvement (κ=0.41). Twenty-one cases were under-staged and five cases were over-staged with regards to invasion of the muscularis propria. Fourteen cases were under-staged, and two cases over-staged in regards to lymph node involvement.
Although MRI provides important pretreatment staging information for rectal adenocarcinoma, in our experience MRI is not as accurate as in other reports. Multidisciplinary teams managing patients with rectal adenocarcinoma should be aware of the limitations of MRI for pretreatment staging.
新西兰是全球直肠腺癌发病率最高的国家之一。磁共振成像(MRI)广泛用于直肠癌的术前分期。MRI的准确性存在差异,这可能会影响治疗决策。新西兰一个省级中心针对直肠腺癌术前分期的MRI准确性尚未得到研究。我们旨在评估通过中中央地区癌症服务多学科团队管理的患者中,MRI对早期直肠腺癌术前分期的准确性。
对中中央地区癌症服务多学科团队数据库进行回顾性分析,确定了54例未接受术前长程放化疗而进行手术的直肠腺癌患者。将这些患者各自的术前MRI分期与组织学分期进行比较。
MRI正确判断肿瘤浸润(T分期)的有24例患者(占病例的44%),正确判断淋巴结分期的有38例患者(占病例的70%)。MRI与组织学分期在肿瘤浸润(κ=0.46)和淋巴结受累情况(κ=0.41)方面有中度一致性。关于固有肌层浸润,21例分期过低,5例分期过高。关于淋巴结受累情况,14例分期过低,2例分期过高。
虽然MRI为直肠腺癌提供了重要的术前分期信息,但根据我们的经验,MRI并不像其他报告中那么准确。管理直肠腺癌患者的多学科团队应了解MRI在术前分期方面的局限性。